Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 28, 2008

View Archived Issues

Nissan Chemical patents novel antithrombocytopenic compounds

New therapeutic agents for thrombotic disorders described in recent patent literature

Novartis reports 2007 results

Regulatory T-cell loss of function triggers type 1 diabetes in mice

Epix achieves milestone in collaboration with Cystic Fibrosis Foundation

FDA Advisory Committee votes favorably for Entereg in postoperative ileus

New treatment options for inflammatory and allergic conditions disclosed in Icos patent

Nabi Biopharmaceuticals initiates new strategic alternatives process

Patient enrollment begins for NIH funded SFP clinical study

Bayer extends its liver cancer product portfolio in Japan

CombinatoRx provides update on 2008 goals

Combination of quetiapine and a mood stabilizer more effective in preventing mood episodes

Data Safety Monitoring Board reviews phase III defibrotide trial

First and only antiinflammatory pain relief patch available in the U.S.

GSK allies with institutions in tuberculosis and malaria drug discovery programs

GSK/MRC to identify new therapeutic targets from genetic association studies

M.D. Anderson and AstraZeneca form cancer-related neuropathic pain alliance

Protherics initiates OncoGel phase IIb study in esophageal cancer

BioCryst updates clinical development plan for intramuscular peramivir

Novartis reports positive primary endpoint from the FIRST-STEP study of Stalevo

Cangene's recombinant human growth hormone approved by the FDA

Kipres approved for additional indication of allergic rhinitis

Promising preclinical results for FGL in stress-induced cognitive deficits

Kirin Pharma launches Regpara tablets for secondary hyperparathyroidism

EMEA recommends approval of novel oral anticoagulant, Pradaxa

Clexane, sanofi-aventis' anticoagulant, is approved for marketing in Japan

Antibacterial Gracevit receives manufacturing and marketing approval in Japan

First launch of Optaflu in Germany

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...